Restart of production in SP5
25 March 2016 Urenco Nederland NewsToday Urenco Nederland restarted the remaining production capacity which had been paused following the incident that occurred on 27 August 2015. Affected areas inside the enrichment plant have been cleaned extensively and installations and systems have been checked and reinstalled. The Authority for Nuclear Safety and Radiation Protection (ANVS) has approved restart of production.
More nederland stories
25th anniversary for enrichment plant SP5
Urenco Nederland 15 May 2025An indispensable asset in the global production capacity of the Urenco Group
Read moreAn indispensable asset in the global production capacity of the Urenco Group
Read moreUrenco Isotopes launches Blaise Pascal installation to expand its critical supply
Urenco Nederland 14 May 2025This expansion comes at a crucial time as the global shortage of critical isotopes continues to impact various sectors.
Read moreThis expansion comes at a crucial time as the global shortage of critical isotopes continues to impact various sectors.
Read moreAbout Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries